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Hypertension is highly prevalent but remains poorly controlled in Canada, the United States and 
European countries [1-4]. Reasons include clinical inertia, patients’ limited access to health care, lack 
of awareness or underestimation of the importance of lifestyle factors, and nonadherence to blood 
pressure (BP) lowering medication [1]. Challenges exist at every level of hypertension management, 
and accordingly, solutions for improving hypertension control rates should be multilevel. 
 
One innovative solution for improving hypertension care is shared care through team-based care 
(TBC). TBC is a coordinated model of shared care involving different healthcare professionals, such 
as physicians, pharmacists, nurses, or other health care professionals, working in collaborative 
partnership, each with their own expertise [5]. An important member of the team is the pharmacist 
who is a valuable asset to improve hypertension management given his accessibility and drug therapy 
expertise [6]. Several meta-analyses of randomized trials have shown significant reductions in BP 
when pharmacists were involved compared to usual care [7-9]. In addition, pharmacist-led 
interventions appear to be cost-effective. Indeed, Marra et al showed a net cost savings of $CDN 15.7 
billion if only 50% of Canadians had their hypertension care provided by a prescribing pharmacist, 
compared to usual care [10-12]. Recent guidelines on hypertension management, notably the 2017 
Guidelines from the American College of Cardiology Foundation and American Heart Association 
(ACC/AHA), recommend for the first time TBC [13]. Moreover, the ACC/AHA recommendations are 
in line with recent recommendations of Hypertension Canada and the European Society of 
Hypertension [14, 15]. In this brief review, we discuss the recommendations for TBC for hypertension 
management in recent American, Canadian, and European guidelines and pinpoint roles and 
responsibilities that fall within the scope of care provided by a pharmacist. 
 
Recommendations from guidelines  
 
The 2017 ACC/AHA Guidelines for hypertension management strongly recommend TBC. These 
guidelines give a formal definition of TBC, identify members of the team-based care, specify patient 
circumstances where TBC is recommended, and define roles and responsibilities of the team at every 
level of hypertension management [13]. Table 1 compares the 2017 ACC/AHA guidelines with 
recommendations from the 2018 Guidelines from the Task Force for the management of arterial 
hypertension of the European Society of Cardiology and the European Society of Hypertension 
(ESC/ESH) and Hypertension Canada’s 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, 
and Treatment of Hypertension in Adults [14, 15]. The American ACC/AHA Guidelines emphasize 
TBC more than the European ESC/ESH and Hypertension Canada’s 2017 Guidelines by providing a 
more exhaustive definition of TBC, including the composition of the team. The three guidelines assign 
roles and responsibilities in hypertension management on the level of the team as an entity, but no firm 




The pharmacist’s role in the team 
 
The ACC/AHA Guidelines give examples of the roles of each team member, particularly pharmacists. 
The responsibilities of pharmacists include “comprehensive medication management, which involves 
identification and documentation of medication-related problems, initiating, modifying, and 
discontinuing medication to address identified problems, and educating patients on their medication 
regimen” [13]. The scope of pharmacists can be broadened to almost every step of hypertension 
management, at the patient as well as the team organization levels. Indeed, recent systematic reviews 
by Santschi et al. have found that pharmacists interventions that reach beyond the scope of medication 
management are more effective in reducing BP compared to standard of care [8, 9]. Table 2 compares 
the responsibilities and tasks of the hypertension management team as stated in the ACC/AHA and 
Canadian guidelines with pharmacists’ interventions shown to be effective. Overall, pharmacists can 
be involved at the patient-level - from diagnosis to BP monitoring, and medication management - and 
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at the team-level for the education of patient and health care providers, and communication and 




For the first time, American guidelines strongly recommend using TBC in hypertension management, 
[13] in line with European and Canadian guidelines. Pharmacists are highly valuable members in team 
care [6], with strong evidence that their involvement in hypertension management improves 
hypertension control as compared to standard of care [7, 8]. Shared care through TBC with the 
involvement of pharmacists should be the standard of care for hypertension. 
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Table 1. American, European and Canadian 2017/18 recommendations regarding TBC in hypertension management  
ACC/AHA 2017 Guideline for the Prevention, 
Detection, Evaluation, and Management of High 
Blood Pressure in Adults [13] 
ESC/ESH 2018 Guidelines for the 
management of arterial 
hypertension [15] 
Hypertension Canada’s 2017 
Guidelines for Diagnosis, Risk 
Assessment, Prevention, and 
Treatment of Hypertension in 
Adults [14] 
Members of the care 
team  
TBC for hypertension includes the patient, the 
patient’s primary care provider, and other 
professionals, such as cardiologists, nurses, 
pharmacists, physician assistants, dietitians, social 
workers, and community health workers. These 
professionals complement the activities of the primary 
care provider by providing process support and sharing 
the responsibilities of hypertension care.  
No explicit definition of TBC, but 
guidelines mention that collaboration 
[of physician] with other healthcare 
providers, especially nurses and 
pharmacists may improve drug 
adherence in hypertension. 
No explicit definition of TBC, but 
guidelines recommend both 
involving the patients in their 
treatment to improve adherence and 
coordinating with pharmacists and 
work-site health care givers to 
improve monitoring of adherence 
with pharmacological and lifestyle 
modification prescriptions. 
Formal definition of 
TBC in Management of 
hypertension  
TBC to improve BP control is a health systems–level, 
organizational intervention that incorporates a 
multidisciplinary team to improve the quality of 
hypertension care for patients.   
No explicit definition. No explicit definition. 
Steps in Management of 
hypertension, where 
TBC is recommended 
A TBC approach is patient centered and is frequently 
implemented as part of a multifaceted approach, with 
systems support for clinical decision making (i.e., 
treatment algorithms), collaboration, adherence to 
prescribed regimen, BP monitoring, and patient 
self-management.  Follow-up and monitoring after 
initiation of drug therapy for hypertension control 
should include systematic strategies to help improve 
BP, including use of HBPM, TBC, and telehealth 
strategies. 
[…] nurses and pharmacists [have an 
important role] in the education, 
support, and follow-up of treated 
hypertensive patients (part of the 
overall strategy to improve BP 
control).  Increasing the integration 
among healthcare providers with the 
involvement of pharmacists and 
nurses increases drug adherence.  
A multidisciplinary team approach is 
recommended for improving 
adherence to an antihypertensive 
prescription and in strategies 
targeting weight loss (dietary 
education, increased physical 








No recommendation. No recommendation. 
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(1) patients who do 
not respond to or do 
not tolerate treatment 
with several 
medications 
Working with this more demanding subset requires 
provider expertise, patience, and a mechanism to 
respond efficiently and sensitively to concerns as they 
arise. In this setting, TBC may be effective, 
encouraging coupling of non-pharmacological and 
pharmacological treatments, while improving access 
to and communication with care providers.  
  
(2) older adults (≥65 
years of age) with 
hypertension and a 




[…] clinical judgment, patient preference, and a TBC 
approach to assess risk/benefit is reasonable for 
decisions regarding intensity of BP lowering and 





It is crucial to invest in measures to enhance health 
literacy and reinforce the importance of adhering to 
treatment strategies, while paying attention to cultural 
sensitivities. These measures may include identification 
of and partnering with community resources and 
organizations devoted to hypertension control and 
cardiovascular health. Although comparative-
effectiveness data documenting efficacy of various 
interventions are limited, multidisciplinary team–based 
approaches and the use of community health workers 
have shown some utility, as has the use of out-of office 
BP monitoring (or no-cost BP control visits), 
particularly among resource-constrained populations. 
  
Abbreviations: ACC/AHA, American College of Cardiology Foundation and American Heart Association; ESH/ESC, the Task Force for the management of 
arterial hypertension of the European Society of Cardiology and the European Society of Hypertension; TBC: team-based care; BP: blood pressure; HBPM, home 
blood pressure monitoring.  
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Table 2. Responsibilities and tasks in hypertension management that can be assigned to a multidisciplinary team in recent American and Canadian Guidelines 
compared to roles of pharmacists that have been shown to be effective in managing hypertension 
Level in hypertension 
management 
Responsibilities of a team as 
recommended in the ACC/AHA 
Guidelines 2017 [13] 
Tasks of a team as recommended in the 
Hypertension Canada’s 2017 Guidelines [14] 
Pharmacists’ interventions 
shown effective in systematic 
reviews [8, 9] 
Role in managing BP 
and hypertension on a 
patient-level 




Effective use of evidence-based 
diagnosis and management guidelines.  
Health care professionals who have been specifically 
trained to measure BP accurately should assess BP in 
all adult patients at all appropriate visits to determine 
cardiovascular risk and monitor antihypertensive 
treatment.  
Measurement of BP, 
hypertension staging and risk 
of stratification, and reviewing 
of home BP measurements. 
Medication 
management 
Medication addition and titration using 
evidence-based treatment algorithms. 
Tailoring pill-taking to fit patient’s daily habits 
simplifying to once-daily dosing, single pill 
combinations and unit-of-use packaging (of several 
medications to be taken together). 
Medication management 
(including drug monitoring 
with adjustment or change in 
medication). 
BP monitoring and 
follow-up aids on 
adherence 
Regular, structured follow-up 
mechanisms and reminder systems to 
monitor patient progress. Follow a single, 
personalized plan of care based upon 
patient characteristics and needs.  
Assessing adherence to pharmacological and 
nonpharmacological therapy at every visit. 
Encouraging adherence with therapy by out-of-office 
contact (phone or mail). Utilizing electronic 
medication compliance aids. Coordination with 
pharmacists and work-site health care givers to 
improve monitoring of adherence with 
pharmacological and lifestyle modification 
prescriptions.  
Reminder system (including 
telephone contact, web 
services, home visits, or drug 
adherence aid). 
Roles in organizing 
hypertension 







Communication and care coordination 
among various team members, the patient 
No recommendation. Feedback to healthcare 
professional (including drug-
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within the care 
team 
and family members or other support 
persons. 
related problems identification; 
recommendation to physician 
for medication change; team 





Medication adherence support and 
appropriate education about hypertension 
medication. Engage patients in their care 
by shared decision making. Use of 
evidence-based tools and resources 
designed to maximize self-management 
(including health behavior change, 
lifestyle modification, etc.). 
Increasing patient involvement in their treatment by 
encouraging greater patient responsibility/autonomy 
in monitoring their BP and adjusting their 
prescriptions. Educating patients and their families 
about their disease and treatment regimens. Being 
involved in weight loss strategies including dietary 
education, counseling on physical activity, and 
performing behavioral interventions. 
Patient education and 
counseling about lifestyle, 
medication and medication 
adherence. 
Education of health 
care professional  
No recommendation. No recommendation. Healthcare professional 
education (including training 
program). 
Abbreviation. ACC/AHA, American College of Cardiology Foundation and American Heart Association; TBC: team-based care; BP: blood pressure.   
